Investor Presentaiton
Organic revenue growth and stable margins in every year since 2007
Ongoing
revenue
(US$m)
Divestments following
portfolio review and
COVID-19
pandemic
Global
financial crisis
FX translation effect
5,179
5,357
4,713
4,772
4,810
4,855
4,485
4,657
4,477
4,059
4,214
4,335
3,821
3,859
3,424
1,255
1,309
1,387
1,306
1,385
1,290
1,306
1,175
1,195
1,199
Benchmark
EBIT
(US$m)
996
1,046
938
939
808
FY07 FY08 FY09
FY10
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18
FY19
FY20
FY21
Organic revenue
growth
Benchmark EBIT
margin
8%
4%
3%
2%
8%
10%
8%
5%
1%
5%
5%
5%
9%
8%
4%
21.8%
21.8% 23.3%
24.4%
24.8%
26.2% 26.6% 27.4%
27.2% 26.7%
27.7%
27.7%
26.9% 26.8% 25.9%
1. Conversion of Benchmark EBIT into Benchmark operating cash flow.
Global ongoing activities revenue and Benchmark EBIT only. Excluding growth rates, FY07 to FY20 revenue, Benchmark EBIT and cash flow conversion may have been adjusted to exclude various exited business activities and
discontinued operations. Growth rates are not restated. All revenue, Benchmark EBIT and conversion of Benchmark EBIT into Benchmark operating cash flow, are as reported. Source: Experian's Annual Reports from FY07 to FY20 (see
www.experianplc.com/investors/reports/).
27
Experian Public
experian.View entire presentation